19% Response Rate for Women With Triple Negative Breast Cancer That's Positive to the Biomarker PDL-1 Respond to Immunotherapy

19% Response Rate for Women With Triple Negative Breast Cancer That's Positive to the Biomarker PDL-1 Respond to Immunotherapy

User Photo
AnnualMeeting-SITC2017

3 years
387 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Heather McArthur, MD of Cedars-Sinai Medical Center discusses the importance of checkpoint blockade in breast cancer. With the biomarker PDL-1, there has been a 19% response rate in women with triple negative breast cancer. This was recorded at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando, Florida.
Up Next Autoplay
User Photo